Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Leukostasis D018921 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Migraine without Aura D020326 1 associated lipids
Mouth, Edentulous D009066 1 associated lipids
Anthrax D000881 1 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Noguchi K et al. The detection of platelet-activating factor in inflamed human gingival tissue. 1989 Arch. Oral Biol. pmid:2783040
Feliste R et al. Protective effect of BN 52021, a specific antagonist of platelet-activating factor (PAF-acether) against diet-induced cholesteryl ester deposition in rabbit aorta. 1989 Atherosclerosis pmid:2783199
Senn N and Garay RP Regulation of Na+ and K+ contents in rat thymocytes. 1989 Am. J. Physiol. pmid:2546433
Lippe IT and Holzer P The diacylglycerol kinase inhibitor, R 59022, suppresses contractility of intestinal smooth muscle. 1989 Eur. J. Pharmacol. pmid:2468509
Etienne A et al. Modulation by drugs of eosinophil recruitment induced by immune challenge in the rat. Possible roles of interleukin 5 and platelet-activating factor. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2468617
Cirino G et al. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. 1989 Proc. Natl. Acad. Sci. U.S.A. pmid:2470103
Bregestovski PD and Ryan US Voltage-gated and receptor-mediated ionic currents in the membrane of endothelial cells. 1989 J. Mol. Cell. Cardiol. pmid:2471836
Morimoto H et al. Plasma extravasation by chemical mediators in rat skin and trachea: a role of neurogenic agents on tracheal edema formation. 1989 Jpn. J. Pharmacol. pmid:2473234
Baydoun AR et al. Effects of endothelin-1 on the rat isolated heart. 1989 J. Cardiovasc. Pharmacol. pmid:2473308
Korth R et al. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells. 1989 Br. J. Pharmacol. pmid:2555017
Chao W et al. Regulation of platelet-activating factor receptors in rat Kupffer cells. 1989 J. Biol. Chem. pmid:2555359
Travers JB et al. Identification of functional platelet-activating factor receptors in Raji lymphoblasts. 1989 J. Immunol. pmid:2555416
Hosford D et al. Platelet-activating factor and cytokine interactions in shock. 1989 Resuscitation pmid:2555874
Widdicombe JH et al. Release of cyclooxygenase products from primary cultures of tracheal epithelia of dog and human. 1989 Am. J. Physiol. pmid:2514604
Yoshida N et al. Pathogenesis of platelet-activating factor-induced gastric mucosal damage in rats. 1989 Scand. J. Gastroenterol. Suppl. pmid:2556790
Block LH et al. Platelet-activating factor (PAF)-dependent biochemical, morphologic, and physiologic responses of human platelets: demonstration of translocation of protein kinase C associated with protein phosphorylation. 1989 Am. J. Respir. Cell Mol. Biol. pmid:2624764
Stewart AG et al. Evidence for an intracellular action of platelet-activating factor in bovine cultured aortic endothelial cells. 1989 Br. J. Pharmacol. pmid:2497920
Cucala M et al. Central regulation of gastric acid secretion by platelet-activating factor in anesthesized rats. 1989 Prostaglandins pmid:2499013
Lomazova KD et al. [The thrombocyte-activation factor and endotoxin-induced thrombocyte activation]. 1989 Biull Eksp Biol Med pmid:2500157
Kajiyama Y et al. Pertussis toxin-sensitive GTP-binding proteins may regulate phospholipase A2 in response to thrombin in rabbit platelets. 1989 Arch. Biochem. Biophys. pmid:2505676
Record M et al. Subcellular localization of phospholipids and enzymes involved in PAF-acether metabolism. 1989 J. Cell. Biochem. pmid:2506197
Dembinska-Kiec A et al. The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed. 1989 Prostaglandins pmid:2717778
Hwang SB et al. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors. 1989 Mol. Pharmacol. pmid:2536468
Sirén AL and Feuerstein G Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats. 1989 Am. J. Physiol. pmid:2546449
Bazill GW and Dexter TM An antagonist to platelet activating factor counteracts the tumoricidal action of alkyl lysophospholipids. 1989 Biochem. Pharmacol. pmid:2536543
Barzaghi G and Mong S Platelet activating factor-amidophosphonate (PAF-AP), a partial agonist inhibited platelet activating factor-induced calcium mobilization in human monocytic leukemic U-937 cell. 1989 Life Sci. pmid:2536882
Snyder F Biochemistry of platelet-activating factor: a unique class of biologically active phospholipids. 1989 Proc. Soc. Exp. Biol. Med. pmid:2536942
McColl SR et al. Involvement of guanine nucleotide binding proteins in neutrophil activation and priming by GM-CSF. 1989 Blood pmid:2537115
Barzaghi G et al. Platelet-activating factor-induced phosphoinositide metabolism in differentiated U-937 cells in culture. 1989 J. Pharmacol. Exp. Ther. pmid:2537401
Pirotzky E et al. Involvement of platelet-activating factor in renal processes. 1989 Adv. Lipid Res. pmid:2698054
Hampel G et al. Selenium deficiency inhibits prostacyclin release and enhances production of platelet activating factor by human endothelial cells. 1989 Biochim. Biophys. Acta pmid:2512981
Snyder F et al. Platelet-activating factor and related ether lipid mediators. Biological activities, metabolism, and regulation. 1989 Ann. N. Y. Acad. Sci. pmid:2698076
Okubo K et al. The existence of a platelet-activating factor (Paf-acether)-like substance in blister fluid derived from patients with bullous pemphigoid as demonstrated by human platelet aggregation techniques. 1989 Kurume Med J pmid:2700767
Johnson RA et al. An asymmetric synthesis of (R) and (S)-1-alkoxy-2,3-propanediols including precursors to platelet activating factor. 1989 Chem. Phys. Lipids pmid:2766428
Redkar-Brown DG and Aharony D Inhibition of antigen-induced contraction of guinea pig trachea by ICI 198,615. 1989 Eur. J. Pharmacol. pmid:2767127
Koenderman L and Bruijnzeel PL Increased sensitivity of the chemoattractant-induced chemiluminescence in eosinophils isolated from atopic individuals. 1989 Immunology pmid:2767711
Denizot Y et al. Synthesis of paf-acether from exogenous precursors by the prokaryote Escherichia coli. 1989 FEBS Lett. pmid:2646144
Neuwirth R et al. Extra- and intracellular metabolism of platelet-activating factor by cultured mesangial cells. 1989 Am. J. Physiol. pmid:2705543
Christman BW and Blair IA Analysis of platelet activating factor in human saliva by gas chromatography/mass spectrometry. 1989 Biomed. Environ. Mass Spectrom. pmid:2706378
Varol FG et al. Platelet-activating factor stimulates phosphatidylinositol hydrolysis in the rat myometrium. 1989 Eur. J. Pharmacol. pmid:2707303
Harper MJ et al. Spermicidal effect of antagonists of platelet-activating factor. 1989 Fertil. Steril. pmid:2707465
Burstein SH et al. Antagonism to the actions of platelet activating factor by a nonpsychoactive cannabinoid. 1989 J. Pharmacol. Exp. Ther. pmid:2553925
Mencia-Huerta JM et al. Effect of long-term administration of platelet-activating factor on pulmonary responsiveness and morphology in the guinea pig. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2707878
Danyoshi C et al. Pyrrolidine derivatives as inhibitors of platelet aggregation induced by platelet activating factor. 1989 Chem. Pharm. Bull. pmid:2805179
Macpherson JL et al. Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis. 1989 Clin. Exp. Immunol. pmid:2805409
McCormack DG et al. Evidence against a role for platelet-activating factor in hypoxic pulmonary vasoconstriction in the rat. 1989 Clin. Sci. pmid:2805602
Salem P et al. Presence of paf-acether in human thymus. 1989 FEBS Lett. pmid:2806565
Ricker DD et al. The effects of platelet-activating factor on the motility of human spermatozoa. 1989 Fertil. Steril. pmid:2806605
Guinot P et al. Tanakan inhibits platelet-activating-factor-induced platelet aggregation in healthy male volunteers. 1989 Haemostasis pmid:2807039
Carveth HJ et al. Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins. 1989 Biochem. Biophys. Res. Commun. pmid:2665743
Sánchez Crespo M Biosynthesis of platelet-activating factor: the role of the remodeling pathway. 1989 Methods Find Exp Clin Pharmacol pmid:2666805
Kaminker AJ and Carreras LO [Physiopathology of thrombotic microangiopathy]. 1989 Sangre (Barc) pmid:2667170
Mizushima H et al. Purification of rabbit platelet secretory phospholipase A2 and its characteristics. 1989 J. Biochem. pmid:2668261
Harper MJ Platelet-activating factor: a paracrine factor in preimplantation stages of reproduction? 1989 Biol. Reprod. pmid:2669984
Badr KF et al. Glomerular responses to platelet-activating factor in the rat: role of thromboxane A2. 1989 Am. J. Physiol. pmid:2912165
Hong JL et al. [Effects of tetrandrine on cytoplasmic free calcium in rat neutrophils]. 1989 Zhongguo Yao Li Xue Bao pmid:2561935
Bazill GW and Dexter TM Platelet activating factor antagonist L-652,731 inhibits thymidine transport. 1989 Biochem. Pharmacol. pmid:2914023
VornovitskiÄ­ EG et al. [Cardiodepressive effect of platelet activating factor]. 1989 Biull Eksp Biol Med pmid:2914168
Gallin EK Evidence for a Ca-activated inwardly rectifying K channel in human macrophages. 1989 Am. J. Physiol. pmid:2750892
Palmantier R et al. Biosynthesis of paf-acether. XIV. Paf-acether output in murine peritoneal macrophages is regulated by the level of acetylhydrolase. 1989 Biochem. Biophys. Res. Commun. pmid:2751666
Ontell SJ et al. Pharmacologic modulation of experimental postischemic hepatic function. 1989 Ann. Surg. pmid:2916864
Gelas P et al. Differential activation by fMet-Leu-Phe and phorbol ester of a plasma membrane phosphatidylcholine-specific phospholipase D in human neutrophil. 1989 FEBS Lett. pmid:2753160
Filep J et al. Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog. 1989 Biochem. Biophys. Res. Commun. pmid:2916986
Tilley JW et al. Biphenylcarboxamide derivatives as antagonists of platelet-activating factor. 1989 J. Med. Chem. pmid:2754708
Camoratto AM and Grandison L Platelet-activating factor stimulates prolactin release from dispersed rat anterior pituitary cells in vitro. 1989 Endocrinology pmid:2917522
Guthrie RW et al. Pentadienyl carboxamide derivatives as antagonists of platelet-activating factor. 1989 J. Med. Chem. pmid:2754709
Esplugues JV and Whittle BJ Mechanisms contributing to gastric motility changes induced by PAF-acether and endotoxin in rats. 1989 Am. J. Physiol. pmid:2919672
Oda M et al. [Platelet-activating factor producing cell--target cell interactions]. 1989 Rinsho Byori pmid:2754814
Straube W [Which signals of early pregnancy are known currently, what cer- tainty have they and exactly how far are they applicable in practice?]. 1989 Zentralbl Gynakol pmid:2655355
Takayasu M et al. Endothelin-induced mobilization of Ca2+ and the possible involvement of platelet activating factor and thromboxane A2. 1989 Biochem. Biophys. Res. Commun. pmid:2655596
Pretolani M et al. From anti-asthma drugs to PAF-acether antagonism and back. Present status. 1989 Biochem. Pharmacol. pmid:2655601
Esplugues JV and Whittle BJ Gastric effects of PAF. 1989 Methods Find Exp Clin Pharmacol pmid:2657290
Makino S [Platelet-activating factor and disease]. 1989 Kokyu To Junkan pmid:2657915
Townley RG et al. Platelet-activating factor and airway reactivity. 1989 J. Allergy Clin. Immunol. pmid:2659646
Miadonna A et al. Evidence of PAF-acether metabolic pathway activation in antigen challenge of upper respiratory airways. 1989 Am. Rev. Respir. Dis. pmid:2546468
Camussi G et al. Tumor necrosis factor stimulates human neutrophils to release leukotriene B4 and platelet-activating factor. Induction of phospholipase A2 and acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase activity and inhibition by antiproteinase. 1989 Eur. J. Biochem. pmid:2546764
Spina D et al. The role of platelet activating factor in allergic inflammation. 1989 Pulm Pharmacol pmid:2520484
De Vos C et al. Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2523357
Benfenati E et al. Development of a mass spectrometric method to quantitate platelet activating factor in mouse urine. 1989 J. Lipid Res. pmid:2621424
Sueoka K et al. In-vivo and in-vitro determination of components of rabbit early pregnancy factors. 1989 J. Reprod. Fertil. pmid:2621714
Marx MH et al. Darmstoff analogues. 3. Actions of choline esters of acetal phosphatidic acids on visceral smooth muscle. 1989 J. Med. Chem. pmid:2724301
Cucala M et al. CNS effects of platelet-activating factor on the rat stomach. 1989 Methods Find Exp Clin Pharmacol pmid:2725123
Schirmer WJ et al. Systemic and renal hemodynamic response to platelet activating factor. 1989 Prog. Clin. Biol. Res. pmid:2726980
Sanjar S et al. Inhibition of PAF-induced eosinophil accumulation in pulmonary airways of guinea pigs by anti-asthma drugs. 1989 Jpn. J. Pharmacol. pmid:2593375
Iwai A et al. Role of PAF in ischemia-reperfusion injury in the rat stomach. 1989 Scand. J. Gastroenterol. Suppl. pmid:2595310
Binnaka T et al. Gastric mucosal damage induced in rats by intravenous administration of platelet-activating factor. 1989 Scand. J. Gastroenterol. Suppl. pmid:2595311
Hatakeyama K et al. Platelet activating factor induced gastric damage in rats: participation of increased gastric vascular permeability. 1989 Scand. J. Gastroenterol. Suppl. pmid:2595312
García-Sáinz JA Intercellular communication within the liver has clinical implications. 1989 Trends Pharmacol. Sci. pmid:2595791
Bradley LM et al. Circulatory effects of PAF-acether in newborn piglets. 1989 Am. J. Physiol. pmid:2912183
PAF antagonists in asthma. 1989 Lancet pmid:2564116
Heidel JR et al. Characterization of arachidonic acid metabolism, superoxide production, and bacterial killing in bovine circulating neutrophils and elicited alveolar neutrophils. 1989 J. Leukoc. Biol. pmid:2543724
Küster LJ and Frölich JC PAF-induced platelet aggregation and TXB2 formation. 1989 Thromb. Res. pmid:2922704
Randriamampita C and Trautmann A Biphasic increase in intracellular calcium induced by platelet-activating factor in macrophages. 1989 FEBS Lett. pmid:2544447
Uhl D [Platelet activating factor and platelet activating factor antagonists. New methods in asthma therapy?]. 1989 Med Monatsschr Pharm pmid:2544789
Neiman J et al. Platelet responses to platelet-activating factor are inhibited in alcoholics undergoing alcohol withdrawal. 1989 Thromb. Res. pmid:2617478
Chau LY et al. Photoaffinity labeling of platelet activating factor binding sites in rabbit platelet membranes. 1989 Biochem. Biophys. Res. Commun. pmid:2545193
Thierry A et al. Presence of specific platelet-activating factor binding sites in the rat retina. 1989 Eur. J. Pharmacol. pmid:2545464
Marquis O et al. Evidence for the existence and ionic modulation of platelet-activating factor receptors mediating degranulatory responses in human polymorphonuclear leukocytes. 1989 J. Pharmacol. Exp. Ther. pmid:2545861
Kraemer R and Mullane KM Neutrophils delay functional recovery of the post-hypoxic heart of the rabbit. 1989 J. Pharmacol. Exp. Ther. pmid:2553929
Ichikawa Y et al. [Effect of glycyrrhizin on the production of platelet-activating factor from rat peritoneal exudate cells]. 1989 Arerugi pmid:2783037